Last reviewed: June 29, 2026
Last updated: June 29, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, a GLP-1 receptor agonist originally developed for diabetes management, has emerged as one of the most effective weight loss medications available today. Research from the STEP trials shows that patients on semaglutide lose significantly more weight than those on diet and exercise alone—but the exact amount varies based on individual factors like genetics, starting weight, and adherence to treatment.
How Much Weight Do Semaglutide Users Lose on Average?
Clinical trial data reveals that semaglutide users achieve an average weight loss of 10-15% of their initial body weight over 68 weeks of treatment. In the STEP 3 trial specifically, patients taking the highest dose (2.4 mg weekly) lost approximately 17% of their starting weight compared to 3% in the placebo group. These results represent a meaningful change for most adults seeking to reduce health risks linked to excess weight.
Weight loss typically occurs in phases: the first 4-8 weeks show initial drops as the medication reduces appetite and increases feelings of fullness, followed by steady losses over months 2-6. After month 6, weight loss often stabilizes or progresses more gradually. The variation in individual outcomes depends on adherence, dietary choices, exercise habits, and how your body's peptide pathways respond to the medication.
Factors That Influence Your Personal Weight Loss Results
Not everyone experiences identical weight loss on semaglutide because human metabolism is shaped by both genetics and lifestyle. Your GLP-1 receptor sensitivity, insulin production patterns, and appetite-regulating hormones all play critical roles in how effectively the medication works for you. PlexusDx's Precision Peptide Genetic Test examines variants in genes like GLP1R rs6923761, MC4R rs17782313, and FTO rs9939609 to map your individual peptide pathways and predict medication responsiveness.
Dose escalation also affects outcomes: patients who titrate to the full 2.4 mg weekly dose typically see greater weight loss than those using lower maintenance doses. Your starting weight matters too—individuals with higher initial BMI often achieve larger absolute weight losses, though percentage loss tends to be similar. Diet quality, consistent physical activity, sleep patterns, and stress management all amplify semaglutide's effects beyond the medication's direct action.
Semaglutide Injection vs. Oral Forms: Which Delivers Better Results?
Semaglutide injections deliver systemic medication through subcutaneous administration, achieving higher bioavailability and more predictable blood levels than oral tablets. Injectable semaglutide typically produces faster and more pronounced weight loss in clinical studies because the full dose reaches your system without stomach acid degradation. PlexusDx's compounded semaglutide injection starts at $149 per month and maintains consistent pricing regardless of your dose level—your dose goes up, but your price stays the same.
Oral semaglutide requires higher doses to achieve similar effectiveness due to absorption limitations in the digestive tract, and it must be taken on an empty stomach for optimal bioavailability. Some patients prefer oral administration for convenience, while others see superior results with injectable therapy. Your PlexusDx provider can help you select the formulation best suited to your goals, genetics, and lifestyle preferences.
Timeline: When to Expect Weight Loss on Semaglutide
Most patients notice appetite suppression within the first 1-2 weeks of starting semaglutide, though measurable weight loss typically appears between weeks 2-4. By week 12, you should see a 3-5% reduction from your starting weight if you're following consistent nutrition and activity guidelines. Sustained weight loss continues through months 4-6, with the most significant reductions occurring between months 2 and 4 as your body adapts and your dose stabilizes.
After 6 months on semaglutide, weight loss rate often slows—this is not treatment failure but rather your body reaching a new equilibrium. Some patients continue losing weight through month 12, while others maintain their achieved loss. PlexusDx monitoring and the optional Precision Peptide Genetic Test can help your provider adjust your treatment strategy if progress plateaus, ensuring you maximize results from your personalized therapy.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is 10-15% weight loss realistic for me personally?
Individual results vary widely based on genetics, adherence, and starting weight. The Precision Peptide Genetic Test from PlexusDx analyzes your GLP1R and MC4R variants to predict your likely responsiveness, helping set realistic expectations. Patients who combine semaglutide with consistent dietary changes and exercise typically achieve results within or exceeding the 10-15% average range.
How long until I see weight loss results on semaglutide?
Most patients experience reduced appetite within 1-2 weeks and measurable weight loss by week 3-4. Significant reductions (5-10%) typically appear by the 12-week mark. Full results depend on reaching your optimal maintenance dose, which usually takes 8-12 weeks of gradual titration.
Can I get semaglutide without insurance at PlexusDx?
PlexusDx delivers compounded semaglutide injections to all 50 states without requiring insurance or membership fees. Pricing starts at $149 per month, with flat pricing across all dose levels. Your dose can increase without increasing your monthly cost, and the medication is HSA/FSA eligible.
What if my weight loss plateaus after a few months?
Weight loss plateaus are common and don't mean the medication has stopped working. Your provider can evaluate whether dose optimization, lifestyle adjustments, or metabolic factors are involved. The Precision Peptide Genetic Test can reveal whether your peptide pathways suggest responsiveness to combination therapy, such as PlexusDx's GLP-Squared dual-compound option.
How does genetic testing improve my weight loss outcomes?
PlexusDx's Precision Peptide Genetic Test ($99 add-on) maps 14 peptide pathways and examines variants like GLP1R rs6923761 and FTO rs9939609 that influence appetite regulation and metabolic rate. Understanding your genetic predispositions allows your provider to personalize dosing, select the optimal medication formulation, and predict which patients may benefit from combination therapy for maximum results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Mastering Your Ozempic 1 mg Pen: A Guide to Clicks and Precise Dosing
Is Ozempic Good for High Blood Pressure?